Cargando…
Illustration of the Impact of Unmeasured Confounding Within an Economic Evaluation Based on Nonrandomized Data
Background: Propensity score (PS) methods are frequently used within economic evaluations based on nonrandomized data to adjust for measured confounders, but many researchers omit the fact that they cannot adjust for unmeasured confounders. Objective: To illustrate how confounding due to unmeasured...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124939/ https://www.ncbi.nlm.nih.gov/pubmed/30288418 http://dx.doi.org/10.1177/2381468317697711 |
_version_ | 1783353106690473984 |
---|---|
author | Guertin, Jason R. Bowen, James M. De Rose, Guy O’Reilly, Daria J. Tarride, Jean-Eric |
author_facet | Guertin, Jason R. Bowen, James M. De Rose, Guy O’Reilly, Daria J. Tarride, Jean-Eric |
author_sort | Guertin, Jason R. |
collection | PubMed |
description | Background: Propensity score (PS) methods are frequently used within economic evaluations based on nonrandomized data to adjust for measured confounders, but many researchers omit the fact that they cannot adjust for unmeasured confounders. Objective: To illustrate how confounding due to unmeasured confounders can bias an economic evaluation despite PS matching. Methods: We used data from a previously published nonrandomized study to select a prematched population consisting of 121 patients (46.5%) who received endovascular aneurysm repair (EVAR) and 139 patients (53.5%) who received open surgical repair (OSR), in which sufficient data regarding eight measured confounders were available. One-to-one PS matching was used within this population to select two PS-matched subpopulations. The Matched PS-Smoking Excluded Subpopulation was selected by matching patients using a PS model that omitted patients’ smoking status (one of the measured confounders), whereas the Matched PS-Smoking Included Subpopulation was selected by matching patients using a PS model that included all eight measured confounders. Incremental cost-effectiveness ratios (ICERs) were assessed within both subpopulations. Results: Both subpopulations were composed of two different sets of 164 patients. Balance within the Matched PS-Smoking Excluded Subpopulation was achieved on all confounders except for patients’ smoking status, whereas balance within the Matched PS-Smoking Included Subpopulation was achieved on all confounders. Results indicated that the ICER of EVAR over OSR differed between both subpopulations; the ICER was estimated at $157,909 per life-year gained (LYG) within the Matched PS-Smoking Excluded Subpopulation, while it was estimated at $235,074 per LYG within the Matched PS-Smoking Included Subpopulation. Discussion: Although effective in controlling for measured confounding, PS matching may not adjust for unmeasured confounders that may bias the results of an economic evaluation based on nonrandomized data. |
format | Online Article Text |
id | pubmed-6124939 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-61249392018-10-04 Illustration of the Impact of Unmeasured Confounding Within an Economic Evaluation Based on Nonrandomized Data Guertin, Jason R. Bowen, James M. De Rose, Guy O’Reilly, Daria J. Tarride, Jean-Eric MDM Policy Pract Original Article Background: Propensity score (PS) methods are frequently used within economic evaluations based on nonrandomized data to adjust for measured confounders, but many researchers omit the fact that they cannot adjust for unmeasured confounders. Objective: To illustrate how confounding due to unmeasured confounders can bias an economic evaluation despite PS matching. Methods: We used data from a previously published nonrandomized study to select a prematched population consisting of 121 patients (46.5%) who received endovascular aneurysm repair (EVAR) and 139 patients (53.5%) who received open surgical repair (OSR), in which sufficient data regarding eight measured confounders were available. One-to-one PS matching was used within this population to select two PS-matched subpopulations. The Matched PS-Smoking Excluded Subpopulation was selected by matching patients using a PS model that omitted patients’ smoking status (one of the measured confounders), whereas the Matched PS-Smoking Included Subpopulation was selected by matching patients using a PS model that included all eight measured confounders. Incremental cost-effectiveness ratios (ICERs) were assessed within both subpopulations. Results: Both subpopulations were composed of two different sets of 164 patients. Balance within the Matched PS-Smoking Excluded Subpopulation was achieved on all confounders except for patients’ smoking status, whereas balance within the Matched PS-Smoking Included Subpopulation was achieved on all confounders. Results indicated that the ICER of EVAR over OSR differed between both subpopulations; the ICER was estimated at $157,909 per life-year gained (LYG) within the Matched PS-Smoking Excluded Subpopulation, while it was estimated at $235,074 per LYG within the Matched PS-Smoking Included Subpopulation. Discussion: Although effective in controlling for measured confounding, PS matching may not adjust for unmeasured confounders that may bias the results of an economic evaluation based on nonrandomized data. SAGE Publications 2017-03-16 /pmc/articles/PMC6124939/ /pubmed/30288418 http://dx.doi.org/10.1177/2381468317697711 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Guertin, Jason R. Bowen, James M. De Rose, Guy O’Reilly, Daria J. Tarride, Jean-Eric Illustration of the Impact of Unmeasured Confounding Within an Economic Evaluation Based on Nonrandomized Data |
title | Illustration of the Impact of Unmeasured Confounding Within an
Economic Evaluation Based on Nonrandomized Data |
title_full | Illustration of the Impact of Unmeasured Confounding Within an
Economic Evaluation Based on Nonrandomized Data |
title_fullStr | Illustration of the Impact of Unmeasured Confounding Within an
Economic Evaluation Based on Nonrandomized Data |
title_full_unstemmed | Illustration of the Impact of Unmeasured Confounding Within an
Economic Evaluation Based on Nonrandomized Data |
title_short | Illustration of the Impact of Unmeasured Confounding Within an
Economic Evaluation Based on Nonrandomized Data |
title_sort | illustration of the impact of unmeasured confounding within an
economic evaluation based on nonrandomized data |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6124939/ https://www.ncbi.nlm.nih.gov/pubmed/30288418 http://dx.doi.org/10.1177/2381468317697711 |
work_keys_str_mv | AT guertinjasonr illustrationoftheimpactofunmeasuredconfoundingwithinaneconomicevaluationbasedonnonrandomizeddata AT bowenjamesm illustrationoftheimpactofunmeasuredconfoundingwithinaneconomicevaluationbasedonnonrandomizeddata AT deroseguy illustrationoftheimpactofunmeasuredconfoundingwithinaneconomicevaluationbasedonnonrandomizeddata AT oreillydariaj illustrationoftheimpactofunmeasuredconfoundingwithinaneconomicevaluationbasedonnonrandomizeddata AT tarridejeaneric illustrationoftheimpactofunmeasuredconfoundingwithinaneconomicevaluationbasedonnonrandomizeddata |